The role of bronchoalveolar lavage in diagnosis and prognosis of COVID-19 patients
F. Patrucco, F. Gavelli, Piero P. Sainaghi, M. Mondoni, M. Bellan, Simona Priora, Valentina Giai Via, Martina Zava, G. Avanzi, R. Vaschetto, P. Balbo, P. Solidoro
求助PDF
{"title":"The role of bronchoalveolar lavage in diagnosis and prognosis of COVID-19 patients","authors":"F. Patrucco, F. Gavelli, Piero P. Sainaghi, M. Mondoni, M. Bellan, Simona Priora, Valentina Giai Via, Martina Zava, G. Avanzi, R. Vaschetto, P. Balbo, P. Solidoro","doi":"10.23736/s2784-8477.22.02037-x","DOIUrl":null,"url":null,"abstract":"SARS-CoV-2 infection diagnosis is mainly based on nasopharyngeal swab real-time reverse-transcriptase-polymerase reaction positivity in the presence of clinical and radiological suspicion of viral infection. In case of negative test, bronchoscopy with bronchoalveolar lavage (BAL) is the most used technique to rule out SARS-CoV-2 infection. The role of BAL in COVID-19 diagnosis is debated since its diagnostic yield is highly influenced by several factors. Nevertheless, the analysis of BAL fluid provides many important information about the COVID-19 alveolar environment. The analysis of alveolar populations, as well as cytokines and chemokine production, may contribute to better understand the pathogenetic mechanisms involved in COVID-19, providing information on patients' prognosis. Moreover, many efforts have been spent on transcriptome analysis of host response to SARS-CoV-2 infection. In this narrative review we explored the role of BAL in diagnosis and prognosis of patients with COVID-19, focusing on its diagnostic yield, on its role in the study of alveolar cytology, cytokines and chemokines production, microbiological coinfection and how they can influence the prognosis of COVID-19 patients. Copyright © 2022 EDIZIONI MINERVA MEDICA.","PeriodicalId":29817,"journal":{"name":"Minerva Respiratory Medicine","volume":"25 1","pages":""},"PeriodicalIF":0.2000,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Minerva Respiratory Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.23736/s2784-8477.22.02037-x","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"RESPIRATORY SYSTEM","Score":null,"Total":0}
引用次数: 0
引用
批量引用
支气管肺泡灌洗在COVID-19患者诊断和预后中的作用
SARS-CoV-2感染的诊断主要是在临床和放射学怀疑病毒感染的情况下,根据鼻咽拭子实时逆转录聚合酶反应阳性。在阴性情况下,支气管镜联合支气管肺泡灌洗(BAL)是排除SARS-CoV-2感染的最常用方法。BAL在COVID-19诊断中的作用存在争议,因为其诊断率受几个因素的高度影响。然而,BAL液的分析提供了许多关于COVID-19肺泡环境的重要信息。对肺泡群以及细胞因子和趋化因子产生的分析可能有助于更好地了解COVID-19的发病机制,为患者的预后提供信息。此外,在宿主对SARS-CoV-2感染反应的转录组分析方面也花费了许多努力。在这篇叙叙性综述中,我们探讨了BAL在COVID-19患者诊断和预后中的作用,重点是其诊断率、在肺泡细胞学、细胞因子和趋化因子产生、微生物共感染研究中的作用以及它们如何影响COVID-19患者的预后。版权所有©2022 EDIZIONI MINERVA MEDICA。
本文章由计算机程序翻译,如有差异,请以英文原文为准。